HF
CRL icon

HRT Financial’s Charles River Laboratories CRL Stock Holding History

HRT Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,618
Closed -$5.4M – 2974
2025
Q2 		$5.4M Buy
+35,618
New +$4.75M 0.02% 496
2024
Q4 		– Sell
-14,769
Closed -$2.91M – 2544
2024
Q3 		$2.91M Buy
+14,769
New +$3.07M 0.01% 714
2024
Q2 		– Sell
-4,856
Closed -$1.31M – 2351
2024
Q1 		$1.31M Buy
+4,856
New +$1.16M 0.01% 756
2023
Q3 		– Sell
-22,835
Closed -$4.8M – 2496
2023
Q2 		$4.8M Buy
22,835
+6,002
+36% +$1.19M 0.04% 298
2023
Q1 		$3.4M Buy
+16,833
New +$3.81M 0.04% 378
2022
Q3 		– Sell
-9,891
Closed -$2.12M – 2907
2022
Q2 		$2.12M Buy
+9,891
New +$2.42M 0.02% 546
2021
Q2 		– Sell
-58,879
Closed -$17.1M – 2951
2021
Q1 		$17.1M Buy
58,879
+1,990
+3% +$553K 0.17% 67
2020
Q4 		$14.2M Buy
56,889
+18,401
+48% +$4.38M 0.29% 58
2020
Q3 		$8.71M Buy
+38,488
New +$7.99M 0.25% 68
2019
Q4 		– Sell
-7,104
Closed -$940K – 1220
2019
Q3 		$940K Buy
+7,104
New +$952K 0.04% 384

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HRT Financial's CRL Position: Q3 2025 in Review

HRT Financial sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 35,618 shares — an estimated $5.4M sold.

HRT Financial first reported a position in CRL in Q3 2019 and held it in 10 quarters. The position peaked at $17.1M in Q1 2021. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • HRT Financial reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 35,618 Charles River Laboratories shares in Q3 2025, an estimated $5.4M.
  • HRT Financial first reported a position in Charles River Laboratories in Q3 2019 and held it in 10 quarters.
  • HRT Financial's Charles River Laboratories position peaked at $17.1M in Q1 2021.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.